The HINT3 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the HINT3 gene in the HT29 human colorectal adenocarcinoma cell line. This polyclonal pool provides a heterogeneous loss-of-function model, avoiding clonal selection bias and enabling population-level analysis of HINT3-dependent mitochondrial processes. CRISPR/Cas9-mediated gene disruption abrogates HINT3 protein expression, establishing a versatile platform for investigating mitochondrial nucleotide metabolism and energy homeostasis in a colorectal cancer context.
HT29 cells are a widely used adherent epithelial line derived from a primary colorectal adenocarcinoma of a 44-year-old female. They serve as an intestinal epithelial model for studying colorectal cancer biology, drug absorption, and barrier function. HT29 cells possess functional mitochondria and exhibit both oxidative phosphorylation and glycolysis, making them particularly relevant for examining the role of mitochondrial enzymes like HINT3 in tumor cell metabolism and metabolic adaptation.
HINT3 encodes a mitochondrial adenosine 5′-monophosphoramidase that hydrolyzes AMP-NH2 to AMP and ammonia, a step implicated in adenine nucleotide homeostasis. HINT3 interacts with ATP5O, the OSCP subunit of ATP synthase, modulating ATP synthesis efficiency. Upstream, HINT3 expression is regulated by mitochondrial biogenesis signals, including the transcriptional coactivator PGC-1?? and nuclear respiratory factor 1 (NRF1). Downstream, HINT3 activity impacts cellular ATP levels, mitochondrial membrane potential, and the AMPK energy-sensing pathway. Additional key components of this signaling network include ATP synthase subunits ATP5F1A and ATP5F1B. Disruption of HINT3 thus perturbs mitochondrial AMP-NH2 hydrolysis, leading to dysregulation of ATP synthase, altered adenine nucleotide pools, and compromised cellular energy homeostasis.
In HT29 colorectal cancer cells, HINT3 knockout provides a critical tool to probe the link between mitochondrial nucleotide metabolism and oncogenic metabolic reprogramming. Colorectal cancers frequently rewire energy metabolism to support proliferation, and HINT3 loss may impair ATP synthase function, inducing compensatory metabolic shifts and potential therapeutic vulnerabilities. The polyclonal knockout format reflects the genetic heterogeneity of tumors, enhancing translational relevance. This model allows dissection of HINT3??s specific contributions to oxidative phosphorylation, purine metabolism, and ATP synthesis, and facilitates investigation of synthetic lethal interactions with chemotherapeutics or targeted agents.
Researchers can employ these cells in a variety of functional assays, including western blotting for OXPHOS proteins, ATP level quantification, mitochondrial membrane potential measurement with JC-1 or TMRM, and Seahorse metabolic flux analysis to assess oxygen consumption and extracellular acidification rates. Additional applications include drug sensitivity screening, apoptosis assays (Annexin V), RT-qPCR for metabolic gene expression, cell viability (MTT), and migration/invasion studies. For further information, contact Ascent Research.
